TheraPsil

TheraPsil.

Media Kit

Download Backgrounder

Introduction.

Here are some of the topics TheraPsil, is ready to discuss.

• How British Columbia/Canada is at the forefront of legal/decriminalized psychedelic therapies
• Drug Discovery and the efficacy of psychedelic intervention for palliative care patients.
• Psychedelic Medicine in Mental Health creating access for Canadian patients
• Canadian Psychedelics Recent Section 56(1) exemption
• Learnings from being First Movers in the Psychedelic Space, lawyers, advocates, and patient rights
• Safeguarding the medical use of Psilocybin, ensuring that Investments are sound and preventing the over commodification of “psychedelic medicine”
• COVID-19 and the After Effects of Isolation on mental health in Canada
• The right to die in Canada
• Potential for Psychedelic medical discovery and research on Canadian economy

Topics that TheraPsil would be able to provide comment/insights about…

• The Pre-Clinical Trial
• Process (where we are at in terms of determining medical efficacy for psychedelic interventions)
• Patient rights in Canada and end-of-life Cancer Care
• Palliative Medicine
• Organic versus Synthetic Molecules
• Drug Discovery Timeline
• Legal Challenge Timeline

Mission: TheraPsil’s 4 Pillars.

COMPASSIONATE ACCESS: Establish safe, compassionate, and legal access to psychedelic-assisted therapy for those in medical need.

PUBLIC EDUCATION: Increase awareness of general public and health care professionals about the merits and limitations of psychedelic-assisted therapy.

PROFESSIONAL TRAINING: Developing safe, simple, and effective protocols for credentialed health professionals across Canada to deliver psilocybin-assisted therapy, in collaboration with other active organizations.

RESEARCH: Facilitate research and evaluation, in collaboration with Canadian and international partners.

Vision: Why They Exist.

• Canadians in palliative care with severe psychological distress deserve access to effective new therapies, in consultation with a physician, which can improve their quality of life/death.
• When effective therapy involves a prohibited/controlled substance, we challenge the laws that are in conflict with science and compassionate care.
• Care providers must work collaboratively with patients toward healing vs merely the suppression of psychological trauma, addiction, illness, and pain.

TheraPsil’s Values.

Freedom

Courage

Compassion

Responsibility

• Freedom of citizens to exercise their right to try therapies and make their own choices about their personal health and wellbeing
• Courage to fight for that right
• Compassion for patients in medical need and with a palliative diagnosis
• Responsibility to mitigate suffering and promote the well-being of patients

Goals.

Lobby Health Minister Patty Hajdu to accept section 56(1) exemptions for the right to access psilocybin on compassionate medical grounds, on behalf of TheraPsil patients who have requested access to end-of-life psychedelic paliation.

The Result? Success, received approval for first four patients as of August 4th 2020.